Finance

Beta
Lists
047920:KOSDAQ
HLB Pharmaceutical Co Ltd
â‚©11,080.00
+0.91%
(+100.00) 1D
Jun 10, 3:30:27 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 047920...
Open
â‚©11,070
High
â‚©11,280
Low
â‚©10,800
Mkt. cap
363.42B
Avg. vol.
116.45K
Volume
51.96K
P/E ratio
97.38
52-wk high
â‚©22,250
52-wk low
â‚©10,500
EPS
â‚©114
Shares outstanding
32.80M
No. of employees
194
Open
â‚©11,070
High
â‚©11,280
Low
â‚©10,800
Mkt. cap
363.42B
Avg. vol.
116.45K
Volume
51.96K
P/E ratio
97.38
52-wk high
â‚©22,250
52-wk low
â‚©10,500
EPS
â‚©114
Shares outstanding
32.80M
No. of employees
194
News stories
From sources across the web
About HLB Pharmaceutical Co Ltd
CEOPark Jae-hyeong
Employees194
Founded1998
Headquarters-
SectorPharmaceutical industry
Websitehlbpharma.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
46.92B
60.59B
63.42B
65.65B
Cost of goods sold
23.42B
32.32B
32.95B
35.60B
Cost of revenue
23.42B
32.32B
32.95B
35.60B
Research and development expenses
685.01M
806.10M
1.12B
1.20B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23.93B
26.71B
27.90B
27.06B
Operating expense
25.29B
28.24B
29.64B
29.02B
Total operating expenses
48.71B
60.56B
62.59B
64.62B
Operating income
-1.79B
34.12M
834.84M
1.03B
Other non operating income
-169.48M
-191.60M
2.10B
-254.81M
EBT including unusual items
1.27B
-164.03M
2.42B
715.03M
EBT excluding unusual items
1.27B
-165.16M
2.24B
685.03M
Income tax expense
355.94M
-3.43M
168.44M
-5.07M
Effective tax rate
28.12%
2.09%
6.95%
-0.71%
Other operating expenses
87.26M
109.54M
79.11M
93.46M
Net income
909.68M
-160.60M
2.25B
720.10M
Net profit margin
1.94%
-0.27%
3.55%
1.10%
Earnings per share
-
-
-
-
Interest and investment income
184.32M
187.15M
162.23M
114.66M
Interest expense
-177.04M
-193.93M
-186.34M
-178.33M
Net interest expenses
7.28M
-6.78M
-24.11M
-63.68M
Depreciation and amortization charges
216.81M
248.64M
184.02M
298.01M
EBITDA
-799.03M
1.10B
1.90B
2.22B
Gain or loss from assets sale
-
-535.00K
51.00M
-30.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer